References
- Ichioka S, Kudo S, Shibata M, Ando J, Sekiya N, Nakatsuka T. Bone marrow cell implantation improves flap viability after ischemia-reperfusion injury. Ann Plast Surg 2004;52:414–18.
- Yamaguchi Y, Kubo T, Murakami T, Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. Br J Dermatol 2005;152:616–22.
- Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003;139:510–16.
- Falanga V, Iwamoto S, Chartier M, Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007;13:1299–312.
- Humpert PM, Bartsch U, Konrade I, Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient. Exp Clin Endocrinol Diabetes 2005;113:538–40.
- Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg 2001;54:659–64.
- Ichioka S, Ohura N, Sekiya N, Shibata M, Nakatsuka T. Regenerative surgery for sacral pressure ulcers using collagen matrix substitute dermis (artificial dermis). Ann Plast Surg 2003;51:383–9.
- Ichioka S, Kouraba S, Sekiya N, Ohura N, Nakatsuka T. Bone marrow-impregnated collagen matrix for wound healing: experimental evaluation in a microcirculatory model of angiogenesis, and clinical experience. Br J Plast Surg 2005;58:1124–30.
- Ichioka S, Yokogawa H, Sekiya N, . Determinants of wound healing in bone marrow impregnated collagen matrix treatment: impact of microcirculatory response to surgical debridement. Wound Repair Regen 2009;17:492–7.
- Simon DA, Dix FP, McCollum CN. Management of venous leg ulcers. BMJ 2004;328:1358–62.
- Grey JE, Harding KG, Enoch S. Venous and arterial leg ulcers. BMJ 2006;332:347–50.
- Drinkwater SL, Smith A, Sawyer BM, Burnand KG. Effect of venous ulcer exudates on angiogenesis in vitro. Br J Surg 2002;89:709–13.
- Abbade LP, Lastoria S. Venous ulcer: epidemiology, physiopathology, diagnosis and treatment. Int J Dermatol 2005;44:449–56.
- Pascarella L, Schonbein GW, Bergan JJ. Microcirculation and ulcers: a review. Ann Vasc Surg 2005;19:921–7.
- Cianfarani F, Tommasi R, Failla CM, Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 2006;154:34–41.
- Drinkwater SL, Burnand KG, Ding R, Smith A. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers. J Vasc Surg 2003;38:1106–12.
- Trengove NJ, Bielefeldt-Ohmann H, Stacey MC. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000;8:13–25.
- Agren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous legs ulcers is ulcer-age dependent. J Invest Dermatol 1999;112:463–9.
- Asahara T, Masuda H, Takahashi T, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221–8.
- Asahara T, Murohara T, Sullivan A, Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964–7.
- Fathke C, Wilson L, Hutter J, Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 2004;22:812–22.
- Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003;196:245–50.
- Ono I, Tateshita T, Inoue M. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction. J Biomed Mater Res 1998;6:621–30.
- Tateshita T, Ono I, Kaneko F. Effects of collagen matrix containing transforming growth factor (TGF)-beta(1) on wound contraction. J Dermatol Sci 2001;25:104–13.
- Kubo K, Kuroyanagi Y. Development of a cultured dermal substitute composed of a spongy matrix of hyaluronic acid and atelo-collagen combined with fibroblasts: cryopreservation. Artificial Organs 2004;28:182–8.